| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/30/1998 | CA2240458A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 04/29/1998 | EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/29/1998 | EP0838217A2 Cosmetic composition containing neuropeptide Y receptor antagonist |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837927A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837839A2 9-substituted porphycenes |
| 04/29/1998 | EP0722448A4 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/29/1998 | CN1180359A Ascomycins |
| 04/29/1998 | CN1179950A Non-scar neutral burn ointment |
| 04/28/1998 | US5744499 Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744156 Use of a substance P antagonist for the treatment of skin reddening of neurogenic origin |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |
| 04/28/1998 | US5744127 Sunscreens in cosmetics and stabilization of synthetic polymers |
| 04/28/1998 | US5744125 Oxidative polymerization of precursors that enhance substantivity or adherence to hair or skin |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016251A1 New carrier systems |
| 04/23/1998 | WO1998016203A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268405A1 Stabilized gas-supersaturated emulsions and suspensions |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0746294A4 Absorption enhancers for topical pharmaceutical formulations |
| 04/22/1998 | EP0741686B1 New leukotriene b4 derivatives, methods of preparing them and their use as drugs |
| 04/22/1998 | EP0708755B1 Novel vitamin d analogues |
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | CN1179304A Shampoo containing gypsophila extract and its producing technique |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741642 Assay for detecting the expression of a gene encoding human keratinocyte growth factor (KGF) |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015550A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015549A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015548A1 1,4-disubstituted piperazines |
| 04/16/1998 | WO1998015284A2 Mycosis vaccines |
| 04/16/1998 | WO1998015276A1 Compositions and methods for modulating melanin production |
| 04/16/1998 | WO1998015260A1 Wrinkling modifiers |
| 04/16/1998 | WO1998015255A1 Cosmetic or dermatological microemulsions |
| 04/16/1998 | DE19641672A1 Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen Cosmetic or dermatological preparations with a basis of ethylenoxidfreien and propylene oxide-free emulsifiers for the preparation of microemulsion |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267835A1 1,4-disubstituted piperazines |
| 04/16/1998 | CA2267691A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2242525A1 Compositions and methods for modulating melanin production |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835932A1 Non- glycosylated FGF-4 and compositions containing the same |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835118A2 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739137 Enzyme inhibitor treating skin disorder, hair baldness, glandular disorder and prostatic hyperplasia |
| 04/14/1998 | US5739102 Wound healing |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739013 Enzymatic synthesis of 2',5'-oligoadenylate-2',3'-cyclophosphates and treatment of papillomaviruses |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014222A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | WO1998014190A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267111A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | CA2265558A1 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0834322A2 Mycosis vaccine |
| 04/08/1998 | EP0834317A1 Ameliorant for pruritus cutaneous accompanying renal failure |
| 04/08/1998 | EP0834306A2 Water in oil cosmetic emulsion with high electrolyte content |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |
| 04/08/1998 | EP0833630A1 Novel benzopyran compounds and methods for their use |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | CN1178120A Chinese medicines for burns and scalds and preparation thereof |
| 04/08/1998 | CN1178109A Medicine for burn and scald |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736508 Administering streptolysin an antiscarring agent, wound healing agent and for aging resistance |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736154 Multilayered, intra-lesional, interferon delivery which doesn't pass into blood stream; for treatuble carcinomas |
| 04/07/1998 | US5736128 Cosmetic composition for rejuvenation of skin without skin irritation |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA2216006A1 W/o emulsion with high electrolyte content and its use in dermo-cosmetics, in particular for treating irritation and/or sensitive skin |
| 04/07/1998 | CA2084193C 3-amino-2-aryl quinuclidines |
| 04/02/1998 | WO1998013492A2 Isolation and use of motoneuronotrophic factors |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013049A1 Method for preparing a product in particular for preventing and curing skin diseases, and resulting product |
| 04/02/1998 | WO1998013043A1 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases |